Low Morphine Doses in Opioid-Naive Cancer Patients with Pain
β Scribed by Sebastiano Mercadante; Gianpiero Porzio; Patrizia Ferrera; Fabio Fulfaro; Federica Aielli; Corrado Ficorella; Lucilla Verna; Walter Tirelli; Patrizia Villari; Edoardo Arcuri
- Book ID
- 113740813
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 84 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0885-3924
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract There is emerging data supporting the use of TTSβF (transdermal therapeutic systemβfentanyl) in opioid naive patients. Our study examines the safety and efficacy of TTSβF in the longβterm control of cancer pain in opioid naive patients and those transferring from oral morphine. Pain was
## BACKGROUND. Elderly patients are more likely to be affected by the acute and chronic toxicities of opioids, but an association between age and long term opioid consumption has not been established clearly in patients with advanced cancer. ## METHODS. The computerized records of 197 cancer pa
## BACKGROUND. When a change of opioid is considered, equianalgesic dose tables are used. These tables generally propose a dose ratio of 5:l between morphine and hydromorphone. In the case of a change from subcutaneous hydromorphone to methadone, dose ratios ranging from 1:6 to 1:10 are proposed.